University of Oxford

An 11-year study has found that difficulty hearing speech in noisy environments may be an early sign of dementia. The next step will be to investigate whether treating mid-life hearing impairments can reduce the risk of dementia developing later on.

A big flush of funding in the UK is pushing new research on ways to diagnose and treat long COVID. A University of Cambridge team is now working on a blood test to objectively diagnose this emerging chronic condition using immune biomarkers.

Sharks have been around a long time, so it should come as no surprise to hear that even the first humans had run-ins with them. Scientists have now discovered evidence of the earliest-known such attack, which occurred 3,000 years ago in Japan.

University of Oxford researchers have come up with a way to control the speed at which tomatoes ripen by modifying a specific gene. This could not only help reduce wastage and boost tomato crop yields, but possibly other crop varieties, too.

A study from the University of Oxford has analyzed 30 years of data tracking the relationship between young peoples’ technology engagement and mental health, from television watching to smartphone social media use, and found little to no association.

Results from a trial testing a new malaria vaccine have revealed an impressive 77 percent efficacy, higher than any prior vaccine trialled. The vaccine is the first to reach a WHO goal of at least 75 percent efficacy and a larger trial is now underway.

UK researchers are set to re-infect a cohort of recovered COVID-19 patients to study how the immune system responds to a second encounter with SARS-CoV-2. This trial expands on an ongoing study infecting healthy subjects to test vaccine efficacy.

A first-of-its-kind study from Oxford University has investigated the relationship between well-being and time spent playing video games. The surprising findings revealed a small correlation between longer play-times and positive well-being.

AstraZeneca and the University of Oxford have presented the first interim data from their Phase 3 COVID-19 vaccine trial. The vaccine is safe, up to 90 percent effective, and significantly easier to distribute compared to other options.

A new analysis of US patient data has found nearly one in five people are diagnosed with a psychiatric illness within three months of a positive COVID-19 test. The study suggests recovered patients are twice as likely to suffer from anxiety or depression.

New research reveals a novel drug, designed to break up the aggregations of toxic proteins associated with Parkinson’s disease, can effectively slow the disease in mouse models. The researchers are now looking at moving toward human trials.

Following a swift independent investigation, large-scale trials for a COVID-19 vaccine developed by scientists at the University of Oxford are recommencing across the UK after a suspected adverse reaction triggered a global halt to trials last week.